Journal ArticleDOI
Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency
TLDR
The clinical and immunological variability of PAD is defined, how genetic defects identified in PAD have given insight into B-cell immunobiology is considered, and recent technological advances in genomics and the challenges associated with identifying causal variants are addressed.Abstract:
Predominantly antibody deficiency (PAD) is the most prevalent form of primary immunodeficiency, and is characterized by broad clinical, immunological and genetic heterogeneity. Utilizing the current gold standard of whole exome sequencing for diagnosis, pathogenic gene variants are only identified in less than 20% of patients. While elucidation of the causal genes underlying PAD has provided many insights into the cellular and molecular mechanisms underpinning disease pathogenesis, many other genes may remain as yet undefined to enable definitive diagnosis, prognostic monitoring and targeted therapy of patients. Considering that many patients display a relatively late onset of disease presentation in their 2nd or 3rd decade of life, it is questionable whether a single genetic lesion underlies disease in all patients. Potentially, combined effects of other gene variants and/or non-genetic factors, including specific infections can drive disease presentation. In this review, we define (1) the clinical and immunological variability of PAD, (2) consider how genetic defects identified in PAD have given insight into B-cell immunobiology, (3) address recent technological advances in genomics and the challenges associated with identifying causal variants, and (4) discuss how functional validation of variants of unknown significance could potentially be translated into increased diagnostic rates, improved prognostic monitoring and personalized medicine for PAD patients. A multidisciplinary approach will be the key to curtailing the early mortality and high morbidity rates in this immune disorder.read more
Citations
More filters
Posted Content
Clinical and immunologic phenotype associated with activated ă phosphoinositide 3-kinase delta syndrome 2: A cohort study
Elodie Elkaim,Bénédicte Neven,Julie Bruneau,Kanako Mitsui-Sekinaka,Aurélie Stanislas,Lucie Heurtier,Carrie L. Lucas,Helen F. Matthews,Marie-Céline Deau,Svetlana O. Sharapova,James Curtis,Janine Reichenbach,Catherine Glastre,David A. Parry,Gururaj Arumugakani,Elizabeth M. McDermott,Sara Sebnem Kilic,Motoi Yamashita,Despina Moshous,Hicham Lamrini,Burkhard Otremba,Andrew R. Gennery,Tanya I. Coulter,Isabella Quinti,Jean-Louis Stephan,Vassilios Lougaris,Nicholas Brodszki,Vincent Barlogis,Takaki Asano,Lionel Galicier,David Boutboul,Shigeaki Nonoyama,Andrew J. Cant,Kohsuke Imai,Capucine Picard,Sergey Nejentsev,Thierry Jo Molina,Michael J. Lenardo,Sinisa Savic,Marina Cavazzana,Alain Fischer,Anne Durandy,Sven Kracker +42 more
TL;DR: APDS2 is a combined immunodeficiency with a variable clinical phenotype and Complications are frequent, such as severe bacterial and viral infections, lymphoproliferation, and lymphoma similar to APDS1/PASLI-CD.
Journal Article
Mutations in lrba are associated with a syndrome of immune deficiency and autoimmunity
G Lopez-Herrera,Giacomo Tampella,Manuela Baronio,Massimiliano Vitali,Vassilios Lougaris,Alessandro Plebani,Q Pan-Hammarstroem,L Hammarstroem,Likun Du,Kjell Hultenby,Claudia M. Trujillo-Vargas,Kanchan Phadwal,Anna Katharina Simon,Michel Moutschen,Amos Etzioni,Srugo Ami.,Doron Melamed,Chonghai Liu,P Philippet,Vinciane Dideberg,Asghar Aghamohammadi,N Rezai,V Enright,Hans J. Stauss,P Herholz,Ulrich Salzer,Hermann Eibel,Dietmar Pfeifer,H Velkeen,EM Gertz,AA Schaeffer,Bodo Grimbacher +31 more
TL;DR: In this paper, the authors performed genetic linkage analysis in consanguineous families affected by hypogammaglobulinemia and concluded that mutations in LRBA cause an immune deficiency characterized by defects in B cell activation and autophagy and susceptibility to apoptosis.
Iconographies supplémentaires de l'article : Phosphatase and tensin homolog ( PTEN ) mutation can cause activated phosphatidylinositol 3-kinase ? syndrome–like immunodeficiency
Yuki Tsujita,Kanako Mitsui-Sekinaka,Kohsuke Imai,Tzu-Wen Yeh,Noriko Mitsuiki,Takaki Asano,Hidenori Ohnishi,Zenichiro Kato,Yujin Sekinaka,Kiyotaka Zaha,Tamaki Kato,Tsubasa Okano,Takehiro Takashima,Kaoru Kobayashi,Mitsuaki Kimura,Tomoaki Kunitsu,Yoshihiro Maruo,Hirokazu Kanegane,Masatoshi Takagi,Kenichi Yoshida,Yusuke Okuno,Hideki Muramatsu,Yuichi Shiraishi,Kenichi Chiba,Hiroko Tanaka,Satoru Miyano,Seiji Kojima,Seishi Ogawa,Osamu Ohara,Satoshi Okada,Masao Kobayashi,Tomohiro Morio,Shigeaki Nonoyama +32 more
TL;DR: PTEN loss-of-function mutations can cause APDS-like immunodeficiency because of aberrant PI3K pathway activation in lymphocytes.
Combined immunodeficiency and epstein-barr virus-induced b cell malignancy in humans with inherited cd70 deficiency
TL;DR: In this paper, the authors describe four patients from two unrelated families of different ethnicities with a primary immunodeficiency, predominantly manifesting as susceptibility to Epstein-Barr virus (EBV)related diseases.
References
More filters
Journal ArticleDOI
Targeted NGS: A Cost-Effective Approach to Molecular Diagnosis of PIDs.
TL;DR: Targeted NGS is a cost-effective, first-line genetic test for the evaluation of patients with PIDs, which decreases time to diagnosis, increases diagnostic rate, and provides insight into the genotype–phenotype correlation of PIDs in acost-effective way.
Journal ArticleDOI
Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
Christian Klemann,Christian Klemann,Nadezhda Camacho-Ordonez,Linlin Yang,Zoya Eskandarian,Jessica Rojas-Restrepo,Natalie Frede,Alla Bulashevska,Maximilian Heeg,Moudjahed Saleh Al-Ddafari,Julian Premm,Maximilian Seidl,Sandra Ammann,Sandra Ammann,Roya Sherkat,Nita Radhakrishnan,Klaus Warnatz,Susanne Unger,Robin Kobbe,Anja Hüfner,T. Ronan Leahy,Winnie Ip,Winnie Ip,Siobhan O. Burns,Siobhan O. Burns,Manfred Fliegauf,Bodo Grimbacher +26 more
TL;DR: It is concluded that heterozygous damaging mutations in NFKB2 represent a distinct PID entity exceeding the usual clinical spectrum of CVID and thus causes a heterogeneous, more severe form of PID phenotype with early-onset.
Journal ArticleDOI
Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1
Gillian L. Dornan,Braden D. Siempelkamp,Meredith L. Jenkins,Oscar Vadas,Carrie L. Lucas,John E. Burke +5 more
TL;DR: The molecular basis of how PIK3CD and Pik3R1 mutations result in APDS is defined and a potential path to treatment for all APDS patients is revealed and a possible therapeutic strategy for treating patients is provided.
Journal ArticleDOI
Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation.
Shoshana Revel-Vilk,Ute Fischer,Bärbel Keller,Schafiq Nabhani,Laura Gámez-Díaz,Anne Rensing-Ehl,Michael Gombert,Andrea Hönscheid,Hani Saleh,Avraham Shaag,Arndt Borkhardt,Bodo Grimbacher,Klaus Warnatz,Orly Elpeleg,Polina Stepensky +14 more
TL;DR: The phenotypic overlap of other primary immunodeficiencies with ALPS-like disorders is illustrated and the necessity of genetic diagnosis in order to provide early correct diagnosis and subsequent care is strongly underlines.
Journal ArticleDOI
Discovery of single-gene inborn errors of immunity by next generation sequencing.
TL;DR: These findings document the striking heterogeneity of the phenotype in patients with mutations in the same gene, and the surprisingly high frequency of autosomal dominant immunodeficiencies with variable penetrance, and de novo mutations in disorders with a severe phenotype has been unmasked.
Related Papers (5)
Genetic Approaches to the Study of Gene Variants and Their Impact on the Pathophysiology of Type 2 Diabetes
The genetics of common kidney disease: a pathway toward clinical relevance
Paul E. Drawz,John R. Sedor +1 more